No abstract

Combined geochemistry and geochronology of the Myanmar jadeitite were determined. Bulk-rock trace element compositions display U-shaped REE patterns with pronounced positive Eu anomalies. The total REE abundances are very low, less than half chondritic, and the high field strength elements and some large ion lithophile elements are moderately enriched. These features indicate a metasomatic origin. There are three groups of zircons with different interior characteristics, cathodoluminescence, mineral inclusions, chemical compositions and sensitive high-resolution ion microprobe U-Pb ages. Group-I zircons, with a mean age of 163.2 AE 3.3 Ma, mostly have distinct oscillatory zoning, highest U and Th contents, and Na-free, Mg-rich mineral inclusions, and thus indicate an igneous (formation of oceanic crust) or hydrothermal (serpentinization and/or rodingitization) event in the Middle Jurassic. Group-II zircons, with a mean age of 146.5 AE 3.4 Ma, have bright luminescence without oscillatory zoning and include jadeite and jadeitic pyroxene inclusions, suggesting that formation of the Myanmar jadeitites, as well as subduction of the eastern Indian oceanic plate, occurred in the Late Jurassic. Group-III zircons have an age of 122.2 AE 4.8 Ma, which represents a later unknown thermal event. Discovery of the Middle Jurassic zircons provides geochronological constraint on the tectonic evolution of the eastern Indo-Burman Range.

No abstract

No abstract

No abstract

No abstract

A series of tacrine-rhein hybrid compounds have been designed and synthesized as novel multifunctional potent ChE inhibitors. Most of the compounds inhibited ChEs in the nanomolar range in vitro effectively. Compound 10b was one of the most potent inhibitors and was 5-fold more active than tacrine toward AChE, and it also showed a moderate BuChE inhibition with an IC50 value of 200 nM. Kinetic and molecular modeling studies of 10b also indicated that it was a mixed-type inhibitor binding simultaneously to the active and peripheral sites of AChE. In inhibition of the AChE-induced Aβ aggregation assay, compound 10b (70.2% at 100 μM) showed the greatest inhibitory activity. In addition, 10b showed metal-chelating property and low hepatotoxicity. These results suggested that 10b might be an excellent multifunctional agent for AD treatment.

No abstract